Related Experiment Video
Updated: Aug 21, 2026

Analysis of Cell Cycle Position in Mammalian Cells
Published on: January 21, 2012
Transforming growth factor beta-induced cell cycle arrest of human hematopoietic cells requires p57KIP2 up-regulation
Joseph M Scandura1, Piernicola Boccuni, Joan Massagué
1Molecular Pharmacology and Chemistry Program, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
Abstract:
Transforming growth factor beta (TGFbeta) is one of few known negative regulators of hematopoiesis, yet the mechanisms by which it affects cell cycle arrest and stem cell quiescence are poorly understood. Induction of the cyclin-dependent kinase inhibitors, p15INK4b (p15) and p21WAF1 (p21) is important for TGFbeta-mediated cytostasis in epithelial cells but not in hematopoietic cells. Using primary human hematopoietic cells and microarray analysis, we identified p57KIP2 (p57) as the only cyclin-dependent kinase inhibitor induced by TGFbeta. Up-regulation of p57 mRNA and protein occurs before TGFbeta-induced G1 cell cycle arrest, requires transcription, and is mediated via a highly conserved region of the proximal p57 promoter. The up-regulation of p57 is essential for TGFbeta-induced cell cycle arrest in these cells, because two different small interfering RNAs that prevent p57 up-regulation block the cytostatic effects of TGFbeta on human hematopoietic cells. Reduction of basal p57 expression by this approach also allows hematopoietic cells to proliferate more readily in the absence of TGFbeta. p57 is a putative tumor suppressor gene whose expression is frequently silenced by promoter hypermethylation in hematologic malignancies. Our studies identify a molecular pathway by which TGFbeta mediates its cytostatic effects on human hematopoietic cells and suggests an explanation for the frequent silencing of p57 expression.
Insights
Transforming growth factor beta (TGFbeta) halts hematopoietic cell growth by upregulating p57KIP2 (p57). This mechanism is crucial for cell cycle arrest and may explain p57 silencing in blood cancers.
Area of Science:
- Hematology
- Molecular Biology
- Cell Cycle Regulation
Background:
- Transforming growth factor beta (TGFbeta) negatively regulates hematopoiesis.
- Mechanisms of TGFbeta-induced cell cycle arrest and stem cell quiescence in hematopoietic cells are not fully understood.
- Cyclin-dependent kinase inhibitors p15INK4b and p21WAF1 mediate TGFbeta cytostasis in epithelial cells, but not hematopoietic cells.
Purpose of the Study:
- To identify the specific cyclin-dependent kinase inhibitor induced by TGFbeta in human hematopoietic cells.
- To elucidate the molecular pathway by which TGFbeta mediates cytostatic effects on hematopoietic cells.
- To investigate the role of p57KIP2 in TGFbeta-induced cell cycle arrest and its potential link to hematologic malignancies.
Main Methods:
- Primary human hematopoietic cells were used.
- Microarray analysis identified differentially expressed genes.
- Small interfering RNAs (siRNAs) were employed to assess gene function.
- Promoter analysis investigated transcriptional regulation.
Main Results:
- p57KIP2 (p57) was identified as the sole cyclin-dependent kinase inhibitor upregulated by TGFbeta in hematopoietic cells.
- TGFbeta-induced p57 upregulation precedes G1 cell cycle arrest and is transcriptionally dependent.
- siRNA-mediated knockdown of p57 blocked TGFbeta's cytostatic effects and increased basal proliferation.
- p57 promoter hypermethylation is frequent in hematologic malignancies, suggesting a link to silenced expression.
Conclusions:
- TGFbeta mediates cytostasis in human hematopoietic cells primarily through the induction of p57KIP2.
- p57KIP2 is essential for TGFbeta-induced G1 cell cycle arrest in these cells.
- The findings suggest a mechanism for TGFbeta's role in hematopoiesis and provide a potential explanation for p57 silencing in hematologic malignancies.
More Related Videos
07:01Evaluation of Abnormal Growth-related Genes of Hematopoietic Stem and Progenitor Cells by Combining CRISPR/Cas9 Technology with Cell Counting
Published on: May 2, 2025
09:09Preparation of Primary Acute Lymphoblastic Leukemia Cells in Different Cell Cycle Phases by Centrifugal Elutriation
Published on: November 10, 2017
Related Concept Videos
Inhibition of Cdk Activity
Negative Regulator Molecules
Abnormal Proliferation
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Mitogens and the Cell Cycle
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...